Attruby 356 MG tablet 28S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3FK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,437
Award facts
- Contract value 100% obligated
- $13,436.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,436.61 to AmerisourceBergen Drug Corp for Attruby 356 mg tablets (28-count) on January 27, 2026, with an ultimate completion date of February 18, 2026. This firm fixed-price contract, with no set-aside designation, represents a competitive award to the pharmaceutical distributor and represents a task order under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's substantial indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds an even larger IDC with the Defense Logistics Agency valued at $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. These contracts demonstrate the company's extensive capability to supply specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains to the Department of Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM3FK?
SPE2DR26FM3FK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FM3FK worth?
The government has obligated $13,437 on SPE2DR26FM3FK.
Is contract SPE2DR26FM3FK an order under another contract?
Yes. SPE2DR26FM3FK is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3FK competed?
The extent of competition for SPE2DR26FM3FK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award